Clinical TrialsSearch results
Number of results: 324
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to an Alpha-Glucosidase Inhibitor
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2008-10-01
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to a Thiazolidine
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2008-10-01
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to a Metformin
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2009-04-01
Recruiting
- Usefulness of mast cell activation test
- anaphylaxis
- Takazawa Tomonori
- 2022-09-02
Recruiting
- The study for identifying the culprit agents of in-hospital and out-of-hospital anaphylaxis
- anaphylaxis
- Takazawa Tomonori
- 2021-09-23
Recruiting
- Laboratory tests to support the clinical diagnosis of anaphylaxis in healthy volunteers
- anaphylaxis
- Takazawa Tomonori
- 2022-01-21
Recruiting
- Examination of histamine/tryptase threshold for the diagnosis of perioperative anaphylaxis
- Anaphylaxis
- Takazawa Tomonori
- 2021-11-22
Not yet recruiting
- Skin testing and BAT in healthy volunteers
- Anaphylaxis
- Takazawa Tomonori
- 2021-07-09
Other
- A phase III of KTZ-S 2% for Seborrhoeic dermatitis of the scalp
- Seborrhoeic dermatitis of the scalp
- Takahashi Hiromasa
- 2024-01-26
Other
- Efficacy of surgery vs. radiofrequency ablation on primary hepatocellular carcinoma: a prospective cohort study
- A case without informed consent for SURF-RCT among primary hepatocellular carcinoma cases with tumor foci numbering less than 3, each measuring 3 cm or less, Child-Pugh score of 7 or less, ages between 20 and 79 year, and indications for either surgical resection or radiofrequency ablation for the treatment
- Surgery vs. RFA (SURF) trial group
- 2009-04-01